New photodynamic molecular beacons (PMB) as potential cancer-targeted agents in PDT.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2017-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2017.12.034PMID 29338907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix metalloproteinase-based photodynamic molecular beacons for targeted destruction of bone metastases in vivo

  2016cited by this paper
• Lumican Inhibits SNAIL-Induced Melanoma Cell Migration Specifically by Blocking MMP-14 Activity

  2016cited by this paper
• Rational design of matrix metalloproteinase-13 activatable probes for enhanced specificity.

  2014cited by this paper
• Phenotiazinium Dyes as Photosensitizers (PS) in Photodynamic Therapy (PDT): Spectroscopic Properties and Photochemical Mechanisms

  2012cited by this paper
• Photosensitizer-Conjugated Gold Nanorods for Enzyme-Activatable Fluorescence Imaging and Photodynamic Therapy

  2012cited by this paper
• A complete compilation of matrix metalloproteinase expression in human malignant gliomas.

  2012cited by this paper
• Photodynamic molecular beacons triggered by MMP-2 and MMP-9: influence of the distance between photosensitizer and quencher onto photophysical properties and enzymatic activation.

  2012cited by this paper
• Photodynamic therapy of cancer: An update

  2011cited by this paper
• Targeted photodynamic therapy — a promising strategy of tumor treatment

  2011cited by this paper
• In vivo optical imaging of membrane-type matrix metalloproteinase (MT-MMP) activity.

  2011cited by this paper
• High-affinity peptide against MT1-MMP for in vivo tumor imaging.

  2011cited by this paper
• Activatable photosensitizers for imaging and therapy.

  2010cited by this paper
• Design and synthesis of phospholipase C and A2-activatable near-infrared fluorescent smart probes.

  2010cited by this paper
• "Zipper" molecular beacons: a generalized strategy to optimize the performance of activatable protease probes.

  2009cited by this paper
• Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers.

  2009cited by this paper
• New trends in molecular imaging of tumor angiogenesis.

  2008cited by this paper
• Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity.

  2007cited by this paper
• Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation

  2007cited by this paper
• Using molecular beacons for cancer imaging and treatment.

  2007cited by this paper
• Matrix metalloproteases: Underutilized targets for drug delivery

  2007cited by this paper
• Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.

  2007cited by this paper
• Photodynamic therapy agent with a built-in apoptosis sensor for evaluating its own therapeutic outcome in situ.

  2006cited by this paper
• Structure and function of matrix metalloproteinases and TIMPs.

  2006cited by this paper
• Protease‐Mediated Phototoxicity of a Polylysine–Chlorine6 Conjugate

  2006cited by this paper
• Roles of membrane‐type matrix metalloproteinase‐1 in tumor invasion and metastasis

  2005cited by this paper
• Lifetime and diffusion of singlet oxygen in a cell.

  2005cited by this paper
• Expression of matrix metalloproteinases and their inhibitors in human brain tumors

  2004cited by this paper
• Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation.

  2004cited by this paper
• Molecular beacons.

  2004cited by this paper
• Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion.

  2003cited by this paper
• Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1‐MMP, MMP‐2 and MMP‐9 in human glioblastomas

  2003cited by this paper
• Matrix metalloproteinases in tumor-host cell communication.

  2002cited by this paper
• Direct Near-infrared Luminescence Detection of Singlet Oxygen Generated by Photodynamic Therapy in Cells In Vitro and Tissues In Vivo¶

  2002cited by this paper
• A Unique Substrate Binding Mode Discriminates Membrane Type-1 Matrix Metalloproteinase from Other Matrix Metalloproteinases*

  2002cited by this paper
• Direct Near‐infrared Luminescence Detection of Singlet Oxygen Generated by Photodynamic Therapy in Cells In Vitro and Tissues In Vivo ¶

  2002cited by this paper
• Efficiencies of fluorescence resonance energy transfer and contact-mediated quenching in oligonucleotide probes.

  2002cited by this paper
• Expression of Matrix Metalloproteinases and Their Inhibitors in Human Brain Tumors

  1999cited by this paper
• A Compilation of Singlet Oxygen Yields from Biologically Relevant Molecules

  1999cited by this paper
• Membrane-type 1 Matrix Metalloprotease (MT1-MMP) Enables Invasive Migration of Glioma Cells in Central Nervous System White Matter

  1999cited by this paper
• Photophysical and photobiological processes in the photodynamic therapy of tumours.

  1997cited by this paper
• Porphyrin building blocks for modular construction of bioorganic model systems

  1994cited by this paper
• A polymeric drug delivery system for the simultaneous delivery of drugs activatable by enzymes and/or light.

  1994cited by this paper
• Principles of fluorescence spectroscopy

  1983cited by this paper
• Dependence of the kinetics of singlet-singlet energy transfer on spectral overlap.

  1969cited by this paper

• Mechanism-guided design of specific-activated photosensitizers for precision photodynamic therapy

  2026cites this paper
• Recent advances in the nanoparticle-based targeted cancer treatment: A review

  2026cites this paper
• Photochemistry of Resveratrol: Beyond the Reactivity of Metal‐Free Porphyrins Immobilized on Lignin

  2025cites this paper
• Activatable Photosensitizers: From Fundamental Principles to Advanced Designs

  2025cites this paper
• Photodynamic therapy and associated targeting methods for treatment of brain cancer

  2023cites this paper
• Synthesis of Photosensitizers Based on Tetrapyrrolic Macrocycles for Combination with Antibiotics: Dual Inactivation of Bacteria.

  2022cites this paper
• Recent Advances in the Enzyme‐Activatable Organic Fluorescent Probes for Tumor Imaging and Therapy

  2022cites this paper
• Gold nanoparticles: synthesis, physiochemical properties and therapeutic applications in cancer.

  2021cites this paper
• Protease‐activated prodrugs: strategies, challenges, and future directions

  2020cites this paper
• Engineering of an intelligent cascade nanoreactor for sequential improvement of microenvironment and enhanced tumor phototherapy

  2020cites this paper
• Porphyrin Molecular Beacons – a New Approach to Osteoarthritis

  2019cites this paper
• Exploiting the Cellular Redox‐Control System for Activatable Photodynamic Therapy

  2019cites this paper
• Advanced Photosensitizer Activation Strategies for Smarter Photodynamic Therapy Beacons.

  2019cites this paper
• Advanced Photosensitizer Activation Strategies for Smarter Photodynamic Therapy Beacons

  2018cites this paper
• Dihydropyrazothiazole derivatives as potential MMP-2/MMP-8 inhibitors for cancer therapy.

  2018cites this paper